Iceland· IS-EU/1/02/224/001-005

Ambirix

A kombinationen (hepatitis a + hepatitis b) product containing hepatitis a virus (inactivated ) adsorbed on aluminium hydroxide hydrated produced on human diploid (mrc-5) cells,hepatitis b surface antigen (rdna) adsorbed on aluminium phosphate [produced in s. cerevisae cells by rdna], registered in Iceland by GlaxoSmithKline Biologicals S.A.*. The same ATC class is registered in 11 of our 19 countries.

ATC J07BC20

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedAmbirixATCJ07BC20REGISTER NO.IS-EU/1/02/224/001-005PACKS LISTED0CHECKEDSeptember 29, 2026

Where it is registered

Kombinationen (hepatitis a + hepatitis b) is registered in 11 of 19 countries.

Countries holding a registration under ATC J07BC20 (kombinationen (hepatitis a + hepatitis b)), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 7 of them publish a price we can compare per daily dose

Kombinationen (hepatitis a + hepatitis b) · ATC J07BC20

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Hepatitis A virus (inactivated ) adsorbed on aluminium hydroxide hydrated produced on human diploid (MRC-5) cells,Hepatitis B surface antigen (rDNA) adsorbed on aluminium phosphate [produced in S. cerevisae cells by rDNA]
Manufacturer
GlaxoSmithKline Biologicals S.A.*
Country
Iceland (IS)
ATC code
J07BC20
ATC class
Kombinationen (Hepatitis A + Hepatitis B)
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/beaac7b2-f324-4fcc-a515-6474564cbbd3
GET /v1/drugs/beaac7b2-f324-4fcc-a515-6474564cbbd3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Stungulyf, dreifa",
  "source": "lyfjastofnun",
  "atc_raw": "J07BC20",
  "marketed": false,
  "strength": "720 ELISA ein./ml + 20 ug/ ml",
  "ma_number": "EU/1/02/224/001-005",
  "substance": "Hepatitis A virus (inactivated ) adsorbed on aluminium hydroxide hydrated produced on human diploid (MRC-5) cells,Hepatitis B surface antigen (rDNA) adsorbed on aluminium phosphate [produced in S. cerevisae cells by rDNA]",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "37498"
}

See everything about kombinationen (hepatitis a + hepatitis b).

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.